Literature DB >> 8990172

PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

J M Pongubala1, M L Atchison.   

Abstract

The transcription factor PU.1 is necessary for the development of multiple hematopoietic lineages and contributes to the activity of the immunoglobulin kappa 3' enhancer. A variety of proteins bind to the 3' enhancer (PU.1, PIP, ATF1, CREM, c-Fos, c-Jun, and E2A), but the mechanism of 3'-enhancer activity and the proteins necessary for its activity are presently unclear. We show here that PU.1 participates with other transcription factors in forming a higher-order complex with 3'-enhancer DNA sequences. Each protein is necessary for formation of this complex. Individually, transcription factors that bind to the 3' enhancer do not appreciably stimulate transcription in a cell type in which the 3' enhancer is normally silent (NIH 3T3). However, mixture of multiple transcription factors (PU.1, PIP, c-Fos, and c-Jun) can greatly activate the enhancer. PU.1 is necessary for maximal enhancer activity, but mutants of PU.1 that lack the transcriptional activation domain are nearly as efficient at stimulating enhancer activity as the wild-type PU.1 protein. PU.1 apparently can activate transcription by playing an architectural role in interactions with other transcription factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990172      PMCID: PMC19254          DOI: 10.1073/pnas.94.1.127

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription.

Authors:  N S Foulkes; E Borrelli; P Sassone-Corsi
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

2.  Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.

Authors:  J M Pongubala; M L Atchison
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.

Authors:  R Paul; S Schuetze; S L Kozak; D Kabat
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Alternative usage of initiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions.

Authors:  V Delmas; B M Laoide; D Masquilier; R P de Groot; N S Foulkes; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

Authors:  J M Pongubala; C Van Beveren; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

7.  Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.

Authors:  S Schuetze; R Paul; B C Gliniak; D Kabat
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

8.  The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.

Authors:  F Moreau-Gachelin; D Ray; M G Mattei; P Tambourin; A Tavitian
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

9.  The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.

Authors:  C Hagemeier; A J Bannister; A Cook; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1.

Authors:  R Paul; S Schuetze; S L Kozak; C A Kozak; D Kabat
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more
  27 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

3.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 5.  Multiple biochemical activities of NM23/NDP kinase in gene regulation.

Authors:  Edith H Postel
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

6.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

8.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

9.  Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential.

Authors:  Suchita Hodawadekar; Fang Wei; Duonan Yu; Andrei Thomas-Tikhonenko; Michael L Atchison
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

10.  Mi2beta shows chromatin enzyme specificity by erasing a DNase I-hypersensitive site established by ACF.

Authors:  Haruhiko Ishii; Hansen Du; Zhaoqing Zhang; Angus Henderson; Ranjan Sen; Michael J Pazin
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.